Prostate Cancer Screening Practices in Europe
Monique Roobol, PhD, discusses prostate cancer screening protocols across different European countries.
Read More
Monique Roobol, PhD
Monique Roobol is Professor Decision Making in Urology and the Head of the scientific research office within the Department of Urology at Erasmus Medical Centre Rotterdam, The Netherlands. She has a masters and a PhD degree in epidemiology.
The last thirty years have been completely dedicated to research on the early detection of prostate cancer. Next to her significant contribution to the European Randomized study of Screening for Prostate Cancer, she co-developed the “Rotterdam Prostate Cancer Risk calculator, a multi-step risk analysis tools to guide laymen and physician in decision making at diagnosis and the study on active surveillance. (PRIAS: Prostate Cancer Research International Active Surveillance.
The scientific research office performs and supports several clinical and population-based screening studies. On average five PhD students are working under Prof. Roobol’s guidance. She is now the PI of ERSPC and co-PI of PRIAS and the Movember Global Action Plan-3 (active surveillance). Since 2018 she is part of the PIONEER European network for big data in prostate cancer. She is board member of the ERSPC Foundation, and the chairwoman of the Dutch Prostate Cancer Research Foundation (SWOP).
Prof. Roobol has (co)-authored over 350 scientific publications, book chapters and reviews. She is an advisory board member of several major trials related to prostate cancer
Prof. Roobol’s research has been awarded with several prices, such as the bi-annual “van Stockum prize” from the Dutch Urological Association for best thesis, the EAU best clinical paper of the year 2009, the European Urology Platinum Award 2011 and 2018 and the BJUI best urological mobile application award 2015.
Talks by Monique Roobol, PhD